Anti-snoring Devices and Snoring Surgery Market Size & Growth Forecast 2027–2036, By Segments (Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Anti-snoring Devices and Snoring Surgery Market size was estimated at USD 1.94 billion in 2026 and is projected to grow at a 6.94% CAGR from 2027 to 2036, surpassing USD 3.79 billion by 2036. The industry revenue for 2027 is calculated at USD 2.05 billion.
Get more details on this report
Request Free Sample ReportAnti-snoring Devices and Snoring Surgery Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 39.86% market share in 2026, supported by established diagnosis pathways, higher patient awareness, and broad access to device-based and surgical treatments through specialized care.
- Asia Pacific is forecast to grow at an 8.36% CAGR as improving sleep disorder diagnosis, greater treatment acceptance, and expanding clinical capacity accelerate adoption of devices and surgical interventions.
Segment Momentum
- Oral Appliances/Mouthpieces accounted for 32.4% of the market in 2026 because they provide a practical, non-surgical solution that fits routine nightly use and offers a familiar approach to snoring management.
- Position Control Devices are the fastest-growing segment as users increasingly prefer less intrusive, behavior-oriented solutions that address sleep-position-related snoring without oral insertion or surgical intervention.
Market Expansion Drivers
- Rising obesity prevalence accelerating obstructive sleep apnea and chronic snoring cases.
- Growth in minimally invasive snoring surgeries and advanced therapeutic device innovation.
- Expansion of home sleep apnea testing and digital sleep monitoring for early diagnosis.
Leading Market Participants
- Top players in the anti-snoring devices and snoring surgery market include ResMed Inc. (United States), Koninklijke Philips N.V. (Netherlands), SomnoMed Limited (Australia), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Inspire Medical Systems Inc. (United States), Apnea Sciences Corporation (United States), Airway Management Inc. (United States), Sleep Well Enjoy Life Ltd. (United Kingdom), Tomed Dr. Toussaint GmbH (Germany), Braebon Medical Corporation (Canada).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.94 billion
- 2027 Estimated Market Size: USD 2.05 billion.
- Projected Market Size: USD 3.79 billion by 2036
- Growth Forecast: 6.94% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Oral Appliances/Mouthpieces (Type)
- Emerging Opportunity Segment: Position Control Devices (Type)
Market Growth Drivers and Industry Trends
Rising obesity prevalence accelerating obstructive sleep apnea and chronic snoring cases
Increasing obesity prevalence is contributing to higher incidence of obstructive sleep apnea and persistent snoring, creating a broader patient pool requiring diagnosis and treatment. The anti-snoring devices and snoring surgery market will benefit as excess weight increases airway obstruction and sleep-related breathing difficulties, prompting greater use of therapeutic interventions. Growing awareness of the health consequences associated with untreated sleep apnea is also encouraging affected individuals to seek clinical evaluation and suitable solutions, supporting demand for oral devices, airway management technologies, and surgical procedures.
Growth in minimally invasive snoring surgeries and advanced therapeutic device innovation
Advances in less invasive surgical techniques are improving treatment options for patients seeking effective management of chronic snoring and airway obstruction. Innovation across the anti-snoring devices and snoring surgery market is enabling the development of therapeutic approaches designed to address anatomical causes while reducing procedural burden and supporting recovery. Greater availability of targeted interventions can expand treatment acceptance among patients who may be reluctant to undergo conventional surgery, while continued device development is broadening the range of clinical options available for different severity levels and patient requirements.
Expansion of home sleep apnea testing and digital sleep monitoring for early diagnosis
The growing use of home-based diagnostic approaches is making evaluation of sleep-related breathing disorders more accessible outside traditional clinical settings. Expansion of home sleep apnea testing will support the anti-snoring devices and snoring surgery market by helping identify obstructive sleep apnea and related snoring conditions at earlier stages, allowing patients to move more quickly toward appropriate treatment. Digital sleep monitoring can also provide continuous information on nighttime breathing patterns and sleep behavior, supporting clinical assessment and encouraging greater engagement with diagnosis and subsequent therapeutic care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising obesity prevalence accelerating obstructive sleep apnea and chronic snoring cases | 2.20% | Low | North America, Europe | High | Near Term |
| Growth in minimally invasive snoring surgeries and advanced therapeutic device innovation | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Expansion of home sleep apnea testing and digital sleep monitoring for early diagnosis | 1.40% | Moderate | North America, Europe | Emerging | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the anti-snoring devices and snoring surgery market, accounting for a 39.86% share in 2026. The region’s leading position is supported by high awareness of sleep-related breathing disorders, established diagnostic and treatment infrastructure, and greater adoption of both non-invasive devices and surgical interventions. Strong access to specialized sleep clinics and healthcare professionals also facilitates diagnosis and treatment selection, while growing recognition of the effects of persistent snoring on sleep quality and overall well-being continues to encourage patients to seek clinical solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market, supported by expanding healthcare infrastructure, improving access to specialized sleep diagnostics, and increasing awareness of sleep disorders. Rising urbanization and changing lifestyles are contributing to greater recognition of sleep-related health concerns, while broader availability of medical technologies is improving treatment accessibility. The region also presents substantial expansion potential as healthcare systems increasingly emphasize early diagnosis and management of conditions associated with disrupted sleep.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Treatment IntegrationGermany emphasizes clinically validated anti-snoring devices and carefully selected surgical procedures within specialized sleep medicine practices. The market prioritizes treatment approaches that improve patient outcomes while supporting long-term management of sleep-related breathing disorders.
France 🇫🇷
Specialist Sleep CareFrance continues integrating anti-snoring therapies within specialized sleep clinics that combine diagnostic assessment with tailored treatment selection. The market values clinically supported devices and surgical options that address patient-specific anatomical and functional needs.
Italy 🇮🇹
Patient-Centered TreatmentItaly's anti-snoring devices and snoring surgery market is evolving through greater awareness of sleep disorders and broader access to specialist care. Providers increasingly recommend individualized combinations of device-based therapies and surgical procedures based on clinical evaluation and patient preferences.
Japan 🇯🇵
Precision Therapy AdoptionJapan increasingly adopts advanced anti-snoring devices designed for patient comfort and consistent use. The market also supports targeted surgical interventions for appropriate cases, reflecting a preference for personalized sleep disorder management strategies.
South Korea 🇰🇷
Minimally Invasive PreferenceSouth Korea is witnessing broader adoption of minimally invasive anti-snoring procedures alongside innovative oral and wearable devices. Healthcare providers focus on improving treatment accessibility while delivering customized solutions that enhance patient compliance and satisfaction.
United States 🇺🇸
Comprehensive Sleep SolutionsThe U.S. anti-snoring devices and snoring surgery market is driven by growing awareness of sleep health and increasing demand for minimally invasive treatment options. Providers continue expanding personalized therapies that combine medical evaluation with device-based and surgical interventions.
Segment Leadership and Growth Trends
Anti-snoring Devices and Snoring Surgery Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Oral Appliances/Mouthpieces (Largest Segment) vs Position Control Devices (Fastest-Growing Segment)
Oral Appliances/Mouthpieces held the largest share of the anti-snoring devices and snoring surgery market in 2026, representing a 32.4% share. Their leading position is supported by their non-invasive nature, ease of use, and suitability for individuals seeking alternatives to surgical interventions or more complex treatment approaches. These devices can help address snoring by modifying oral and airway positioning, making them practical for routine use in appropriate patients. Growing awareness of sleep-related breathing problems and increasing preference for convenient, at-home solutions are supporting demand for oral appliances and reinforcing their established market position.
Position control devices represent the fastest-growing type, driven by increasing recognition of the role that sleeping position can play in snoring and airway obstruction. These devices are designed to encourage users to maintain positions that may help reduce snoring, providing a relatively simple approach to managing positional symptoms. Growing interest in non-invasive sleep solutions, combined with consumer demand for convenient devices that can be incorporated into nightly routines, is supporting adoption. The broader shift toward accessible and self-managed approaches to sleep health is further strengthening growth opportunities for position control devices.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Oral Appliances/Mouthpieces, Nasal Devices, Position Control Devices, Chin Straps, Tongue Stabilizing Devices, EPAP Therapy Devices | Oral Appliances/Mouthpieces | Position Control Devices |
Competitive Landscape and Market Positioning
Major players in the anti-snoring devices and snoring surgery market:
1. ResMed Inc. (United States)
2. Koninklijke Philips N.V. (Netherlands)
3. SomnoMed Limited (Australia)
4. Fisher & Paykel Healthcare Corporation Limited (New Zealand)
5. Inspire Medical Systems Inc. (United States)
6. Apnea Sciences Corporation (United States)
7. Airway Management Inc. (United States)
8. Sleep Well Enjoy Life Ltd. (United Kingdom)
9. Tomed Dr. Toussaint GmbH (Germany)
10. Braebon Medical Corporation (Canada)
The anti-snoring devices and snoring surgery market is progressing through continuous innovation in wearable sleep technologies and minimally invasive treatment solutions. Rising consumer awareness regarding sleep health, combined with advancements in comfort-focused device design, is encouraging broader adoption and strengthening product competitiveness.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| ResMed Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| SomnoMed Limited (Australia) | |||||||
| Fisher & Paykel Healthcare Corporation Limited (New Zealand) | |||||||
| Inspire Medical Systems Inc. (United States) | |||||||
| Apnea Sciences Corporation (United States) | |||||||
| Airway Management Inc. (United States) | |||||||
| Sleep Well Enjoy Life Ltd. (United Kingdom) | |||||||
| Tomed Dr. Toussaint GmbH (Germany) | |||||||
| Braebon Medical Corporation (Canada). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Illusion Aligners | Jun-22 | Illusion Aligners introduced a lightweight oral anti-snoring device designed to alleviate obstructive sleep apnea (OSA) symptoms. By focusing on usability and patient comfort, the product aims to address market demand for non-invasive sleep aids that improve sleep quality and reduce daytime fatigue, expanding the company’s footprint in respiratory wellness. |
| Signifier Medical Technologies | Feb-21 | Signifier Medical Technologies received FDA marketing clearance for a device indicated for the reduction of mild obstructive sleep apnea and snoring in adults. This regulatory achievement enables the company to commercialize its non-invasive intervention technology, providing a clinical alternative to traditional snoring surgeries and continuous airway pressure devices. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Anti-snoring Devices and Snoring Surgery Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Treatment Setting | Home-Based Treatment, Sleep Clinics, Hospitals, Ambulatory Surgical Centers |
| Distribution Channel | Direct Sales, Retail Pharmacies, Specialty Medical Stores, Online Channels |
| Patient Age Group | Pediatric, Adult, Elderly |
Anti-snoring Devices and Snoring Surgery Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Patient Diagnosis and Treatment Pathway Assessment |
|
| Consumer Adoption and Device Preference Analysis |
|
| Reimbursement and Self-Pay Market Evaluation |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the anti-snoring devices and snoring surgery market?
What are the growth projections for the anti-snoring devices and snoring surgery industry?
How is rising obesity prevalence impacting demand for anti-snoring devices and snoring surgery?
How are home sleep apnea testing and digital monitoring changing patient diagnosis and treatment pathways?
Why are Oral Appliances/Mouthpieces the leading segment in the anti-snoring devices and snoring surgery market?
What is driving the growth of Position Control Devices in the anti-snoring devices and snoring surgery market?
Why is North America the leading market for anti-snoring devices and snoring surgery?
What is driving Asia Pacific's growth in the anti-snoring devices and snoring surgery market?
Who are the leading players in the anti-snoring devices and snoring surgery landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization